Here’s what you should know:
1. Researchers are launching a randomized, double-blind, placebo-controlled clinical trial to test the effectiveness of Biomerica’s IBS therapy.
2. The InFoods IBS product allows physicians to identify specific foods that impact a patient’s IBD. If approved, physicians will be able to take a finger stick blood sample to find foods that impact IBS.
3. The study is being conducted at Boston-based Beth Israel Deaconess Medical Center and Ann Arbor-based University of Michigan.
4. The trial will include 180 patients and last up to 14 months.
5. The study results will be used in a FDA 510(k) application seeking FDA approval for the therapy.
More articles on gastroenterology:
TVA Medical to introduce FDA-approved endovascular fistula creation method at surgery centers — 5 insights
Implementing a total joint replacement program in your ASC: 4 lessons from OrthoIllinois Surgery Center
30k joint replacements for SurgCenter Development & more — 8 ASC company key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
